Neue Aspekte des Qualitätsmanagements. Ein Überblick über Neuerungen des Qualitätsmanagements im Krankenhaus

2019 ◽  
Vol 68 (5) ◽  
pp. 439-448
Author(s):  
Vanessa-Emily Schoch ◽  
Marleen Theresa Marleen Theresa
Keyword(s):  
Quality Management ◽  
Regulatory Requirements ◽  
New Developments ◽  
Gesetzliche Vorgaben ◽  
Business Perspective ◽  
Recent Developments ◽  
Technological Developments ◽  
Aktuelle Entwicklungen ◽  
Economic Constraints ◽  
Different Origins

Zusammenfassung Kliniken stehen zunehmend im Spannungsfeld ökonomischer Restriktionen, technologischer Entwicklungen, patientenorientierter Erwartungen und per­sonalabhängiger Möglichkeiten. Eine stetige Sicherung, Verbesserung und Erweiterung der Leistungsfähigkeit sind Aufgabenbereiche des Qualitätsmanagements. Die bisher primär betriebswirtschaftliche Ausrichtung lässt im Untersuchungszeitraum dieses Berichts eine Öffnung für erweiterte, gesellschafts­politische Fragestellungen erkennen. Forderungen nach Transparenz und Effizienz im klinischen Versorgungssystem werden sowohl durch gesetzliche Vorgaben als auch durch Eigeninitiativen gestützt. Die nachfolgend vorgestellte Literaturübersicht dokumentiert neuere Ansätze unterschiedlicher Provenienz zur Verbesserung anstehender Probleme. Sie verschafft einen Überblick über aktuelle Entwicklungen im Qualitätsmanagement und bietet zugleich Orientierungspunkte für die Entwicklung methodologisch fundierter interdisziplinärer Handlungsstrategien. Abstract: New Aspects of Quality Management. An Overview of New Developments in Quality Management in Hospitals Hospitals and clinics are nowadays facing severe challenges regarding economic constraints, technological developments, patient expectations and staff-related opportunities. A comprehensive quality management, that aims to ensure, improve and extend a hospital’s performance is one tool used to solve those challenges. So far, quality management has mainly been viewed from a business perspective. Contrary to that approach, this paper takes specific sociopolitical issues into account as well. The increased demand for transparency and efficiency are supported by both regulatory requirements and hospitals’ own initiatives. Based on a broad literature survey, the authors identify a variety of approaches from different origins to address current and future quality management challenges. The paper furthermore provides an overview over recent developments in the field of quality management. Additionally, this paper guides methodological interdisciplinary strategies.

Comprehensive View on Recent Developments in Hydrogen Evolution Using MoS2 on Si Photocathode: from Electronic to Electrochemical Aspects

2021 ◽  
Author(s):  
Anirudha Jena ◽  
Chih-Jung Chen ◽  
Ho Chang ◽  
Shu-Fen Hu ◽  
Ru-Shi Liu
Keyword(s):  
Hydrogen Evolution ◽  
Water Electrolysis ◽  
Clean Energy ◽  
Alternative Route ◽  
Comprehensive View ◽  
Recent Developments ◽  
Technological Developments

The generation of clean energy is necessary for future technological developments. The utilization of solar illumination to produce H2 from water electrolysis is an alternative route to address the issue....

scholarly journals Regulatory Requirements for the Quality of Allergen Products for Allergen Immunotherapy of Food Allergy

2021 ◽  
Vol 21 (5) ◽  
Author(s):  
Lisa Englert ◽  
Vera Mahler ◽  
Andreas Bonertz
Keyword(s):  
Allergen Immunotherapy ◽  
Major Allergen ◽  
Food Allergies ◽  
Manufacturing Processes ◽  
Critical Element ◽  
Medicinal Products ◽  
Regulatory Requirements ◽  
Quality Aspects ◽  
Allergenic Activity ◽  
Recent Developments

Abstract Purpose of Review Medicinal products for allergen immunotherapy (AIT) of food allergies have gained enormous momentum in recent years. With this new class of products entering marketing authorization procedures, compliance to regulatory requirements becomes a critical element. Here, an overview is provided on specific requirements and aspects concerning the quality control and manufacturing of these products. Recent Findings Recent developments in the field of AIT for food allergies are divers, including products for oral, epicutaneous, and subcutaneous application, most notably targeting egg, milk, and peanut allergy. As the source materials for food AIT product are typically produced for food consumption and not for medicinal purposes, unique challenges arise in the manufacturing processes and controls of these medicinal products. Individual approaches are needed to assure acceptable quality, including control of relevant quantitative and qualitative characteristics. Major characteristics for quality verification include determination of protein content, total allergenic activity, and major allergen content. The applied manufacturing processes need to be established such that relevant process parameters are kept within justified limits and consistency of produced batches is assured. Summary Allergen products for food AIT present specific challenges with respect to quality aspects that differentiate them from other commonly available AIT products. While established regulation is available and provides clear guidance for most aspects, other issues require consideration of new and individual settings relevant here. Consequently, as experience grows, respective amendments to currently available guidance may be needed.

scholarly journals T regulatory cells in childhood arthritis – novel insights

2013 ◽  
Vol 15 ◽  
Author(s):  
Anne M. Pesenacker ◽  
Lucy R. Wedderburn
Keyword(s):  
T Cells ◽  
Juvenile Idiopathic Arthritis ◽  
Regulatory T Cells ◽  
T Regulatory Cells ◽  
Current Knowledge ◽  
Autoimmune Arthritis ◽  
Regulatory Cells ◽  
New Developments ◽  
Childhood Arthritis ◽  
Recent Developments

In recent years, there have been many new developments in the field of regulatory T cells (Treg), challenging the consensus on their behaviour, classification and role(s) in disease. The role Treg might play in autoimmune disease appears to be more complex than previously thought. Here, we discuss the current knowledge of regulatory T cells through animal and human research and illustrate the recent developments in childhood autoimmune arthritis (juvenile idiopathic arthritis (JIA)). Furthermore, this review summarises our understanding of the fields and assesses current and future implications for Treg in the treatment of JIA.

Bewegungserfassung mit faseroptischen Sensoren*/3D motion tracking with fiber-optic sensors

2018 ◽  
Vol 108 (06) ◽  
pp. 479-484
Author(s):  
C. Riehs ◽  
B. Kleiner ◽  
U. Schneider ◽  
A. Verl
Keyword(s):  
Manufacturing Process ◽  
Motion Tracking ◽  
Fiber Optic ◽  
Fiber Optic Sensors ◽  
Attractive Alternative ◽  
Wird Eine ◽  
New Developments ◽  
3D Motion ◽  
Complete Integration ◽  
Aktuelle Entwicklungen

Aufgrund ihrer geringen Dimensionen und Flexibilität stellen Faseroptische Sensoren eine zunehmend attraktive Alternative zu klassischen Sensoren zur Bewegungsmessung dar. Fortschritte in der Herstellung der Sensoren und durch das Verwenden integrierter photonischer Schaltungen wird eine vollständige Integration aller Komponenten bei gleichzeitig geringen Kosten ermöglicht. In diesem Fachaufsatz sollen aktuelle Entwicklungen erörtert und Potenziale für den Einsatz faseroptischer Sensoren dargelegt werden.   Fiber-optic sensors, which use light instead of electricity, are an attractive alternative to classical sensor due to their small size and robustness. Progress in the manufacturing process of the sensors and new developments in the production of integrated photonic circuits, will allow a complete integration of all components, while having little costs. This article covers current developments and show the potentials of fiber-optic sensors.

Cystic Fibrosis: Recent Developments in Diagnosis and Treatment

1986 ◽  
Vol 7 (9) ◽  
pp. 276-286
Author(s):  
Robert C. Stern
Keyword(s):  
Cystic Fibrosis ◽  
Life Expectancy ◽  
Genetic Defect ◽  
Diagnosis And Treatment ◽  
New Developments ◽  
Recent Developments ◽  
Extended Life

Advances in diagnosis and treatment of cystic fibrosis have greatly extended life expectancy and have decreased morbidity. However, further progress requires knowledge of the fundamental genetic defect and how it is related to the pulmonary pathophysiology. Major new developments in both these areas are likely within the next 5 to 10 years.

The QUIPUDATA Case

2011 ◽  
pp. 504-520
Author(s):  
Martin Santana-Ormeno ◽  
Antonio Diaz-Andrade ◽  
Jaime Serida-Nishimura ◽  
Eddie Morris-Abarca
Keyword(s):  
Information Technology ◽  
Quality Management ◽  
Management Model ◽  
Technology Support ◽  
Evolution And Development ◽  
Quality Certification ◽  
Quality Management Model ◽  
Technological Developments ◽  
Technology Tool

This case study shows the way in which a subsidiary company of one of the largest corporations in Peru, Backus Corporation, charged with assisting in the use of information and telecommunications technologies, implemented a quality management model, got the ISO 9001: 2000 certification, and evolved from an information technology support center to a center of benefits. It describes the evolution and development of the quality management model based on indicators used in QUIPUDATA and also describes the steps followed to get a quality certification. Moreover, it details some of the technological developments within the corporation, including the information technology tool that supports the management model and the corporate network.

New Developments and Challenges in Rare Genitourinary Tumors: Non-Urothelial Bladder Cancers and Squamous Cell Cancers of the Penis

2017 ◽  
pp. 330-336
Author(s):  
Jeanny B. Aragon-Ching ◽  
Lance C. Pagliaro
Keyword(s):  
Clinical Trials ◽  
Squamous Cell ◽  
Rare Diseases ◽  
Research Funding ◽  
Diagnosis And Treatment ◽  
New Developments ◽  
Effective Care ◽  
Recent Developments ◽  
Urothelial Bladder ◽  
Genitourinary Cancers

The diagnosis and treatment of rare genitourinary tumors is inherently challenging. The Rare Diseases Act of 2002 initially defined a rare disorder as one that affects fewer than 200,000 Americans. The lack of widely available clinical guidelines, limited research funding, and inaccessible clinical trials often lead to difficulty with treatment decisions to guide practitioners in rendering effective care for patients with rare genitourinary cancers. This article will discuss basic tenets of diagnosis and treatment as well as recent developments and clinical trials in rare non-urothelial bladder cancers and penile squamous cell cancers.

The QUIPUDATA Case

2006 ◽  
pp. 99-115
Author(s):  
Martin Santana-Ormeño ◽  
Antonio Díaz-Andrade ◽  
Jaime Serida-Nishimura ◽  
Eddie Morris-Abarca
Keyword(s):  
Information Technology ◽  
Quality Management ◽  
Management Model ◽  
Technology Support ◽  
Evolution And Development ◽  
Quality Certification ◽  
Quality Management Model ◽  
Technological Developments ◽  
Technology Tool

This case study shows the way in which a subsidiary company of one of the largest corporations in Peru, Backus Corporation, charged with assisting in the use of information and telecommunications technologies, implemented a quality management model, got the ISO 9001: 2000 certification, and evolved from an information technology support center to a center of benefits. It describes the evolution and development of the quality management model based on indicators used in QUIPUDATA and also describes the steps followed to get a quality certification. Moreover, it details some of the technological developments within the corporation, including the information technology tool that supports the management model and the corporate network.

Sign in / Sign up

Export Citation Format

Share Document